CONCERTA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CONCERTA contains one active pharmaceutical ingredient (API):

1 Methylphenidate UNII 4B3SC438HI - METHYLPHENIDATE HYDROCHLORIDE

Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space. Read about Methylphenidate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CONCERTA Extended-release tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BA04	Methylphenidate	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2172H, 2387P, 2388Q, 2432B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514500301117310, 514500302113319, 514500303111417
Country: CA	Health Products and Food Branch	Identifier(s): 02247732, 02247733, 02247734, 02250241
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02842045, 02842051, 02842068, 06876153, 12459057
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1675-MEE-0116, 1709-MEE-0116, 1730-MEE-0116, 1731-MEE-0116
Country: EE	Ravimiamet	Identifier(s): 1313558, 1313569, 1313570, 1313581, 1313659, 1313660
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65148, 65170, 65171, 69988
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 011489, 011555, 012326, 132663
Country: FR	Base de données publique des médicaments	Identifier(s): 60047182, 60756917, 63930084
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 114650, 26470, 26471, 289431, 373870, 373874, 373878, 374088, 376261, 376263, 376265, 376267, 381263, 381265, 381267, 381269
Country: HK	Department of Health Drug Office	Identifier(s): 60002, 60003, 60004, 60005
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-078951991, HR-H-413338677
Country: IE	Health Products Regulatory Authority	Identifier(s): 16901, 16988, 18113
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4626, 4627, 4832, 4982
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179009G1022, 1179009G2029, 1179009G3025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1026826, 1026827, 1026828, 1027108, 1027109, 1027110
Country: MT	Medicines Authority	Identifier(s): AA018/02604, MA018/02601, MA018/02602, MA018/02603
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 136M2002
Country: NG	Registered Drug Product Database	Identifier(s): B4-8146, B4-8147
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 68004, 68012, 69272, 87076
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10792, 10793, 10794, 12323
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100196827, 100196833
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W43107001, W43107002, W43108001, W43108002, W43109001, W43109002
Country: SG	Health Sciences Authority	Identifier(s): 12098P, 12099P, 12100P, 12431P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593035517, 8699593035524, 8699593035531, 8699593035753
Country: US	FDA, National Drug Code	Identifier(s): 50458-585, 50458-586, 50458-587, 50458-588
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/1.2/0322, 37/1.2/0323, 37/1.2/0324, 42/1.2/0282